MedPath

NOVO-GATIFLOXACIN

NOVO-GATIFLOXACIN

Discontinued
DIN Number

02271052

Drug Class

Human

Market Date

N/A

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02271052
AIG Number0142621002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01MA16 GATIFLOXACIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:12.18
Health Canada Classification

ACTIVE INGREDIENTS (1)

GATIFLOXACINActive
Strength: 400 MG
Monograph: GATIFLOXACIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.